William Blair Investment Management LLC decreased its stake in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 3.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 170,705 shares of the company’s stock after selling 5,501 shares during the period. William Blair Investment Management LLC owned approximately 0.91% of Addus HomeCare worth $18,870,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Addus HomeCare in the 2nd quarter worth approximately $344,153,000. Bank of America Corp DE acquired a new position in shares of Addus HomeCare in the second quarter valued at $35,527,000. TimesSquare Capital Management LLC bought a new position in Addus HomeCare in the second quarter worth $31,502,000. Punch & Associates Investment Management Inc. bought a new position in Addus HomeCare in the second quarter worth $20,911,000. Finally, Bank of New York Mellon Corp bought a new position in Addus HomeCare in the second quarter worth $11,219,000. Institutional investors own 95.35% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have issued reports on ADUS shares. TD Cowen boosted their price target on shares of Addus HomeCare from $131.00 to $145.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Barclays increased their price target on shares of Addus HomeCare from $96.00 to $101.00 and gave the stock an “underweight” rating in a research report on Wednesday, November 4th. Wall Street Zen raised Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 7th. Citigroup lowered Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research note on Monday, September 14th. Finally, UBS Group boosted their price target on Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average target price of $136.33.
View Our Latest Stock Report on ADUS
Insider Buying and Selling at Addus HomeCare
In other Addus HomeCare news, EVP David Tucker sold 14,850 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $124.75, for a total value of $1,852,537.50. Following the sale, the executive vice president owned 8,073 shares in the company, valued at approximately $1,007,106.75. The trade was a 64.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Allison sold 98,958 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $123.27, for a total value of $12,198,552.66. Following the transaction, the chief executive officer directly owned 183,150 shares of the company’s stock, valued at approximately $22,576,900.50. This trade represents a 35.08% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 141,894 shares of company stock valued at $17,536,266 in the last 90 days. 4.10% of the stock is currently owned by corporate insiders.
Addus HomeCare Price Performance
Shares of NASDAQ:ADUS opened at $123.00 on Monday. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64. The stock has a market cap of $2.29 billion, a price-to-earnings ratio of 20.50, a P/E/G ratio of 1.62 and a beta of 0.75. The company has a 50 day moving average of $118.39 and a 200-day moving average of $107.25. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $131.59.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.56 EPS. On average, sell-side analysts forecast that Addus HomeCare Corporation will post 6.41 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Featured Articles
- Five stocks we like better than Addus HomeCare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
